牛唐2020-11-06 14:24
医药板块速评(2020.11.05)
1、$Aptevo Therapeutics(APVO)$ 三天涨四倍的背后原因是什么?有哪些股票有类似的爆发潜力?
2、$Regenxbio(RGNX)$ 基因疗法能否重现曙光?
3、次新股破发严重,哪些次新股解禁前有拉升潜力?
$京东(JD)$查看全文
$Aptevo Therapeutics(APVO)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-083313 Act: 34 Size: 1 MB 网页链接
$Aptevo Therapeutics(APVO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-083225 Act: 33 Size: 155 KB 网页链接
$Aptevo Therapeutics(APVO)$ PRE 14A Other preliminary proxy statements Accession Number: 0000950170-24-081568 Act: 34 Size: 1 MB 网页链接
$Aptevo Therapeutics(APVO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0000950170-24-079653 Act: 34 Size: 2 MB 网页链接
$Aptevo Therapeutics(APVO)$ 8-K Current report, item 3.01 Accession Number: 0000950170-24-079672 Act: 34 Size: 158 KB 网页链接
$Aptevo Therapeutics(APVO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002018 Act: 33 Size: 1 KB 网页链接
$Aptevo Therapeutics(APVO)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0000950170-24-079124 Act: 33 Size: 1 MB 网页链接
$Aptevo Therapeutics(APVO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0000950170-24-077621 Act: 33 Size: 1 MB 网页链接
$Aptevo Therapeutics(APVO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0000950170-24-073737 Act: 33 Size: 2 MB 网页链接
$Aptevo Therapeutics(APVO)$ 8-K Current report, item 5.07 Accession Number: 0000950170-24-071338 Act: 34 Size: 176 KB 网页链接